Healthcare Professionals

FAQs on Optrex ActiMist™ Eye Spray

1. "What if I spray Optrex ActiMist™ Eye Spray onto my open eye?"

Optrex ActiMist™ Eye Spray should only be sprayed onto closed eyes. Customers may feel a slight stinging sensation if the product is sprayed onto the open eye. They can be reassured however that this should pass quickly and is not harmful.

2. "How do I know it’s working?"

Dry eye sufferers may be accustomed to eye drops, which flood the eye with moisture. Remind your customers that Optrex ActiMist™ Eye Spray does not work in the same way as a liquid drop. It works at the cause of the problem by helping to repair the tear film to provide clinically proven relief of dry eye symptoms.

3. "Why does Optrex ActiMist™ Eye Spray smell slightly?"

Optrex ActiMist™ Eye Spray is an oil-based product and has a slightly oily smell. It is normal for customers to notice the smell for a few minutes after application, but this will soon dissipate.

4. "How can I make Optrex ActiMist™ Eye Spray extra refreshing?"

Optrex ActiMist™ Eye Spray does not need refrigeration, but customers may enjoy using it at a cooler temperature. Advise them to put the spray bottle in the refrigerator for an hour or so before use (Optrex ActiMist™ Eye Spray should be stored between 2°C and 25°C).

5. "How long can i keep using the spray after opening?"

• A shelf life of 3 years means you should be able to use it until the bottle is finished.
• The sterile spray mechanism means there is no need to throw the bottle away after 28 days like many treatments.

6. "How many doses are in the bottle?"

Each spray bottle contains 100 applications.

7." Where can I learn more about Optrex ActiMist™ Eye Spray?"

Customers should read the information leaflet inside the Optrex ActiMist™ Eye Spray carton before use.

1. NHS Direct – Dry eye syndrome. http://www.nhsdirect.nhs.uk/articles/articleaspx?articleId=137§ionId=9 2. Optrex Focus on Eye Care series. Dry eyes. 3. Korb DR. Tear film – contact lens interactions. In: Lacrimal gland, Tear Film and Dry Eye syndromes. Ed: DA Sullivan. Plenum Press, New York 1994. 4. Heiligenhaus A et al. Diagnostik und Differenzierung von Benetzungsstungen. Ophthalmologie 1995; 92: 6-11. 5. Heiligenhaus A et al. Therapie von Benetzungsstungen. Klin Monatsbl Augenheilkd 1994; 204: 162-168. 6. Lemp MA. Report of the National Eye Institute/Industry workshop on Clinical Trials in Dry Eyes. CLAO J 1995; 21: 221-232. 7. McCulley JP, Shine WE. Tear film structure and dry eye. Contactologia 1998; 20:145-149. 8. McCulley J et al. Impact of evaporation on aqueous tear loss. Trans Am Ophthalmol Soc 2006; 104: 121-128 9. IPSOS Eye Care Usage and Attitudes Study 2007. 10. Gusto Qual Research May 2007. 11. Lee S et al. Ein neues Therapiekonzept zur Behandlung des Trockenen Auges – die Verwendung von Phospholipid-Liposomen. Klin Monatsbl Augenheilkd 2004; 221: 825-836. 12. Dieter D et al. Comparative study of treatment of the dry eye syndrome due to disturbances of the tear film lipid layer with lipid-containing tear substitutes. Klin Monatsbl Augenheilkd 2006; 223:974-983. 13. AC Neilson all outlets, 52 week ending June 2008, volume sales. 14. MacKeen D, Roth H, Doane M. Ocular drug delivery by the lid (lower lid delivery). Invest Ophthalmol Vis Sci 1996; 37: 77. (abstract) 15. Norn MS. Natural fat in external eye. Vital-stained by Sudan III powder. Acta Ophthalmol (Copenh) 1980; 58: 331-336. 16. Clinical knowledge summary, Dry Eye Syndrome. http://cks.library.nhs.uk/dry_eye_syndrome/view_whole_topic